{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:23:44Z","timestamp":1776835424909,"version":"3.51.2"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T00:00:00Z","timestamp":1410307200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10875-014-0088-2","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T07:10:33Z","timestamp":1410246633000},"page":"941-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Combined Immunodeficiency Evolving into Predominant CD4+ Lymphopenia Caused by Somatic Chimerism in JAK3"],"prefix":"10.1007","volume":"34","author":[{"given":"Sol A.","family":"Ban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Salzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha M.","family":"Eibl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Linder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph B.","family":"Geier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisangela","family":"Santos-Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Garncarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Seelbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaan","family":"Boztug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann M.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,10]]},"reference":[{"key":"88_CR1","doi-asserted-by":"crossref","unstructured":"From the Centers for Disease Control. Unexplained CD4+ T-lymphocyte depletion, persons without evident HIV infection, JAMA, 268 (1992) 1254\u20131255.","DOI":"10.1001\/jama.1992.03490100048012"},{"key":"88_CR2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.bor.0000231908.57913.2f","volume":"18","author":"UA Walker","year":"2006","unstructured":"Walker UA, Warnatz K. Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol. 2006;18:389\u201395.","journal-title":"Curr Opin Rheumatol"},{"key":"88_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2007-12-127878","volume":"112","author":"DI Zonios","year":"2008","unstructured":"Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW, et al. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood. 2008;112:287\u201394.","journal-title":"Blood"},{"key":"88_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199302113280601","volume":"328","author":"DK Smith","year":"1993","unstructured":"Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The centers for disease control idiopathic CD4+ T-lymphocytopenia task force. N Engl J Med. 1993;328:373\u20139.","journal-title":"N Engl J Med"},{"key":"88_CR5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/1074-7613(95)90034-9","volume":"2","author":"H Zhou","year":"1995","unstructured":"Zhou H, Glimcher LH. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity. 1995;2:545\u201353.","journal-title":"Immunity"},{"key":"88_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/3081","volume":"20","author":"K Masternak","year":"1998","unstructured":"Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, et al. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet. 1998;20:273\u20137.","journal-title":"Nat Genet"},{"key":"88_CR7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1101\/gad.9.9.1021","volume":"9","author":"V Steimle","year":"1995","unstructured":"Steimle V, Durand B, Barras E, Zufferey M, Hadam MR, Mach B, et al. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 1995;9:1021\u201332.","journal-title":"Genes Dev"},{"key":"88_CR8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/emboj\/16.5.1045","volume":"16","author":"B Durand","year":"1997","unstructured":"Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, et al. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 1997;16:1045\u201355.","journal-title":"EMBO J"},{"key":"88_CR9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00005792-200111000-00006","volume":"80","author":"J Villard","year":"2001","unstructured":"Villard J, Masternak K, Lisowska-Grospierre B, Fischer A, Reith W. MHC class II deficiency: a disease of gene regulation. Medicine (Baltimore). 2001;80:405\u201318.","journal-title":"Medicine (Baltimore)"},{"key":"88_CR10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nri1708","volume":"5","author":"W Reith","year":"2005","unstructured":"Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol. 2005;5:793\u2013806.","journal-title":"Nat Rev Immunol"},{"key":"88_CR11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI3205","volume":"102","author":"FD Goldman","year":"1998","unstructured":"Goldman FD, Ballas ZK, Schutte BC, Kemp J, Hollenback C, Noraz N, et al. Defective expression of p56lck in an infant with severe combined immunodeficiency. J Clin Invest. 1998;102:421\u20139.","journal-title":"J Clin Invest"},{"key":"88_CR12","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1684\/mrh.2011.0286","volume":"24","author":"FY Li","year":"2011","unstructured":"Li FY, Lenardo MJ, Chaigne-Delalande B. Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiency. Magnes Res. 2011;24:S109\u201314.","journal-title":"Magnes Res"},{"key":"88_CR13","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1182\/blood-2011-01-329052","volume":"117","author":"TW Kuijpers","year":"2011","unstructured":"Kuijpers TW, Ijspeert H, van Leeuwen EM, Jansen MH, Hazenberg MD, Weijer KC, et al. Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. Blood. 2011;117:5892\u20136.","journal-title":"Blood"},{"key":"88_CR14","doi-asserted-by":"crossref","unstructured":"Salzer E, Daschkey S, Choo S, Gombert M, Santos-Valente E, Ginzel S., Combined immunodeficiency with life-threatening EBV-associatedlymphoproliferative disorder in patients lacking functional CD27. Haematologica. (2012).","DOI":"10.3324\/haematol.2012.068791"},{"key":"88_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-59745-223-6_14","volume":"134","author":"T Lion","year":"2007","unstructured":"Lion T. Detection of impending graft rejection and relapse by lineage-specific chimerism analysis. Methods in molecular medicine. 2007;134:197\u2013216.","journal-title":"Methods in molecular medicine"},{"key":"88_CR16","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/leu.2012.66","volume":"26","author":"T Lion","year":"2012","unstructured":"Lion T, Watzinger F, Preuner S, Kreyenberg H, Tilanus M, de Weger R, et al. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation. Leukemia. 2012;26:1821\u20138.","journal-title":"Leukemia"},{"key":"88_CR17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.leu.2402753","volume":"17","author":"T Lion","year":"2003","unstructured":"Lion T. Summary: reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection. Leukemia. 2003;17:252\u20134.","journal-title":"Leukemia"},{"key":"88_CR18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0167-5699(95)80117-0","volume":"16","author":"C Pannetier","year":"1995","unstructured":"Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today. 1995;16:176\u201381.","journal-title":"Immunol Today"},{"key":"88_CR19","doi-asserted-by":"crossref","unstructured":"Tosato G, Cohen JI. Generation of Epstein-Barr Virus (EBV)-immortalized B cell lines. Curr Protoc Immunol, Chapter 7 (2007) Unit 7 22.","DOI":"10.1002\/0471142735.im0722s76"},{"key":"88_CR20","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1073\/pnas.94.13.6910","volume":"94","author":"M Chen","year":"1997","unstructured":"Chen M, Cheng A, Chen YQ, Hymel A, Hanson EP, Kimmel L, et al. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. Proc Natl Acad Sci U S A. 1997;94:6910\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"88_CR21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.0105-2896.2005.00220.x","volume":"203","author":"M Pesu","year":"2005","unstructured":"Pesu M, Candotti F, Husa M, Hofmann SR, Notarangelo LD, O\u2019Shea JJ. Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs. Immunol Rev. 2005;203:127\u201342.","journal-title":"Immunol Rev"},{"key":"88_CR22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.gene.6363802","volume":"2","author":"DM Frucht","year":"2001","unstructured":"Frucht DM, Gadina M, Jagadeesh GJ, Aksentijevich I, Takada K, Bleesing JJ, et al. Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun. 2001;2:422\u201332.","journal-title":"Genes Immun"},{"key":"88_CR23","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1182\/blood.V91.3.949","volume":"91","author":"D Brugnoni","year":"1998","unstructured":"Brugnoni D, Notarangelo LD, Sottini A, Airo P, Pennacchio M, Mazzolari E, et al. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase. Blood. 1998;91:949\u201355.","journal-title":"Blood"},{"key":"88_CR24","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.166.8.5245","volume":"166","author":"T Ariga","year":"2001","unstructured":"Ariga T, Kondoh T, Yamaguchi K, Yamada M, Sasaki S, Nelson DL, et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol. 2001;166:5245\u20139.","journal-title":"J Immunol"},{"key":"88_CR25","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.3324\/haematol.11222","volume":"92","author":"K Boztug","year":"2007","unstructured":"Boztug K, Baumann U, Ballmaier M, Webster D, Sandrock I, Jacobs R, et al. Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patient. Haematologica. 2007;92:e43\u20135.","journal-title":"Haematologica"},{"key":"88_CR26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1399-0004.2008.01019.x","volume":"74","author":"K Boztug","year":"2008","unstructured":"Boztug K, Germeshausen M, Avedillo Diez I, Gulacsy V, Diestelhorst J, Ballmaier M, et al. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome. Clin Genet. 2008;74:68\u201374.","journal-title":"Clin Genet"},{"key":"88_CR27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12026-008-8091-4","volume":"44","author":"BR Davis","year":"2009","unstructured":"Davis BR, Candotti F. Revertant somatic mosaicism in the Wiskott-Aldrich syndrome. Immunol Res. 2009;44:127\u201331.","journal-title":"Immunol Res"},{"key":"88_CR28","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1182\/blood.V97.9.2896","volume":"97","author":"T Ariga","year":"2001","unstructured":"Ariga T, Oda N, Yamaguchi K, Kawamura N, Kikuta H, Taniuchi S, et al. T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation. Blood. 2001;97:2896\u20139.","journal-title":"Blood"},{"key":"88_CR29","first-page":"59","volume":"55","author":"R Hirschhorn","year":"1994","unstructured":"Hirschhorn R, Yang DR, Israni A, Huie ML, Ownby DR. Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery. Am J Hum Genet. 1994;55:59\u201368.","journal-title":"Am J Hum Genet"},{"key":"88_CR30","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2008-04-153361","volume":"112","author":"C Speckmann","year":"2008","unstructured":"Speckmann C, Pannicke U, Wiech E, Schwarz K, Fisch P, Friedrich W, et al. Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency. Blood. 2008;112:4090\u20137.","journal-title":"Blood"},{"key":"88_CR31","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJM199611213352104","volume":"335","author":"V Stephan","year":"1996","unstructured":"Stephan V, Wahn V, Le Deist F, Dirksen U, Broker B, Muller-Fleckenstein I, et al. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med. 1996;335:1563\u20137.","journal-title":"N Engl J Med"},{"key":"88_CR32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mrrev.2010.04.002","volume":"705","author":"RP Erickson","year":"2010","unstructured":"Erickson RP. Somatic gene mutation and human disease other than cancer: an update. Mutat Res. 2010;705:96\u2013106.","journal-title":"Mutat Res"},{"key":"88_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-5793(96)00835-6","volume":"393","author":"C Rolling","year":"1996","unstructured":"Rolling C, Treton D, Pellegrini S, Galanaud P, Richard Y. IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. FEBS Lett. 1996;393:53\u20136.","journal-title":"FEBS Lett"},{"key":"88_CR34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nri1688","volume":"5","author":"WJ Leonard","year":"2005","unstructured":"Leonard WJ, Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol. 2005;5:688\u201398.","journal-title":"Nat Rev Immunol"},{"key":"88_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. The Biochemical journal. 2003;374:1\u201320.","journal-title":"The Biochemical journal"},{"key":"88_CR36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cyto.2012.07.002","volume":"60","author":"AJ Tormo","year":"2012","unstructured":"Tormo AJ, Letellier MC, Sharma M, Elson G, Crabe S, Gauchat JF. IL-6 activates STAT5 in T cells. Cytokine. 2012;60:575\u201382.","journal-title":"Cytokine"},{"key":"88_CR37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","volume":"368","author":"JJ O\u2019Shea","year":"2013","unstructured":"O\u2019Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med. 2013;368:161\u201370.","journal-title":"N Engl J Med"},{"key":"88_CR38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","volume":"9","author":"Y Rochman","year":"2009","unstructured":"Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol. 2009;9:480\u201390.","journal-title":"Nat Rev Immunol"},{"key":"88_CR39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","volume":"23","author":"W Liao","year":"2011","unstructured":"Liao W, Lin JX, Leonard WJ. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol. 2011;23:598\u2013604.","journal-title":"Curr Opin Immunol"},{"key":"88_CR40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/cimm.1997.1208","volume":"181","author":"LA Rosenthal","year":"1997","unstructured":"Rosenthal LA, Winestock KD, Finbloom DS. IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts. Cell Immunol. 1997;181:172\u201381.","journal-title":"Cell Immunol"},{"key":"88_CR41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.270.5237.797","volume":"270","author":"SM Russell","year":"1995","unstructured":"Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science. 1995;270:797\u2013800.","journal-title":"Science"},{"key":"88_CR42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/377065a0","volume":"377","author":"P Macchi","year":"1995","unstructured":"Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature. 1995;377:65\u20138.","journal-title":"Nature"},{"key":"88_CR43","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0022-3476(05)80951-5","volume":"123","author":"JL Stephan","year":"1993","unstructured":"Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint-Basile G, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr. 1993;123:564\u201372.","journal-title":"J Pediatr"},{"key":"88_CR44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/humu.1188","volume":"18","author":"LD Notarangelo","year":"2001","unstructured":"Notarangelo LD, Mella P, Jones A, de Saint Basile G, Savoldi G, Cranston T, et al. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency. Hum Mutat. 2001;18:255\u201363.","journal-title":"Hum Mutat"},{"key":"88_CR45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jaci.2012.12.667","volume":"131","author":"F Cattaneo","year":"2013","unstructured":"Cattaneo F, Recher M, Masneri S, Baxi SN, Fiorini C, Antonelli F, et al. Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment. J Allergy Clin Immunol. 2013;131:1136\u201345.","journal-title":"J Allergy Clin Immunol"},{"key":"88_CR46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/clim.2000.4880","volume":"96","author":"M Vihinen","year":"2000","unstructured":"Vihinen M, Villa A, Mella P, Schumacher RF, Savoldi G, O\u2019Shea JJ, et al. Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency. Clin Immunol. 2000;96:108\u201318.","journal-title":"Clin Immunol"},{"key":"88_CR47","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1182\/blood-2003-10-3655","volume":"103","author":"R Nishikomori","year":"2004","unstructured":"Nishikomori R, Akutagawa H, Maruyama K, Nakata-Hizume M, Ohmori K, Mizuno K, et al. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and\/or survival. Blood. 2004;103:4565\u201372.","journal-title":"Blood"},{"key":"88_CR48","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0092-8674(00)81448-8","volume":"93","author":"A Villa","year":"1998","unstructured":"Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell. 1998;93:885\u201396.","journal-title":"Cell"},{"key":"88_CR49","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jaci.2013.01.020","volume":"131","author":"LD Notarangelo","year":"2013","unstructured":"Notarangelo LD. Partial defects of T-cell development associated with poor T-cell function. J Allergy Clin Immunol. 2013;131:1297\u2013305.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0088-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-014-0088-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0088-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T05:43:37Z","timestamp":1598247817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-014-0088-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,10]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1007\/s10875-014-0088-2","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,10]]}}}